{
  "id": 4666923,
  "title": "Lilly adds to immune drug pipeline with $2.9B Merida buyout",
  "url": "https://urgent.news/2026/08/31/lilly-adds-to-immune-drug-pipeline-with-2-9b-merida-buyout",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-08-31T15:23:00.000Z",
  "source": {
    "name": "BioPharma Dive",
    "slug": "biopharma-dive",
    "url": "https://www.biopharmadive.com/news/lilly-merida-acquire-deal-immune-drugs-graves-disease/829152/"
  },
  "original_language": "en",
  "account": null,
  "summary": "The big drugmaker’s latest company acquisition this year is centered around a technology designed to degrade proteins that malfunction in autoimmune disorders.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}